3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
55
Phase 2
2
Phase 3
1
Status
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Breast
1
Conditions
Motor Activity
1
Leukemia, Myeloid, Acute
1
Breast Neoplasms
1
Interventions
Specimen Handling
273
Magnetic Resonance Spectroscopy
226
pembrolizumab
218
Carboplatin
174
Biopsy
164
Cisplatin
157
Nivolumab
155
Cyclophosphamide
139
Radiotherapy
121
Paclitaxel
120
Gemcitabine
113
durvalumab
90
Bevacizumab
89
Dexamethasone
82
Rituximab
81
Oxaliplatin
77
venetoclax
73
atezolizumab
70
Doxorubicin
70
Docetaxel
66
Radiosurgery
65
Fluorouracil
65
Ipilimumab
64
Capecitabine
64
Etoposide
62
Radiation
59
Prednisone
59
Cytarabine
59
Lenalidomide
56
fludarabine
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Methods
×
90 days
×
Clear all
NCT01621659
2026-05-11
TITAN
University of Alberta
Phase 2
Active not recruiting
80 enrolled
NCT07507825
2026-04-02
VHAG
First People's Hospital of Hangzhou
Phase 2
Not yet recruiting
61 enrolled